Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac.
Lancet Infect Dis
; 21(8): 1071-1072, 2021 08.
Article
in English
| MEDLINE | ID: covidwho-1244853
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Vaccines, Inactivated
/
Antibodies, Neutralizing
/
COVID-19 Vaccines
/
SARS-CoV-2
/
COVID-19
/
Antibodies, Viral
Type of study:
Cohort study
/
Observational study
/
Prognostic study
Topics:
Vaccines
/
Variants
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
/
Young adult
Country/Region as subject:
Asia
Language:
English
Journal:
Lancet Infect Dis
Journal subject:
Communicable Diseases
Year:
2021
Document Type:
Article
Affiliation country:
S1473-3099(21)00287-5
Similar
MEDLINE
...
LILACS
LIS